One Health integrated surveillance: a way forward to accelerate schistosomiasis elimination in China
- PMID: 40546706
- PMCID: PMC12182346
- DOI: 10.1016/j.soh.2025.100114
One Health integrated surveillance: a way forward to accelerate schistosomiasis elimination in China
Abstract
Surveillance is an effective approach for disease control and prevention. Being a vector-borne and zoonotic parasitic disease, schistosomiasis has been under comprehensive surveillance in China for several decades, with focus on indicators related to definitive hosts, intermediate hosts, as well as changes of influencing factors. This article reviewed the surveillance system of schistosomiasis in China from the perspective of One Health to provide evidence for the acceleration of elimination. When moving towards elimination with rare new infection occurred in humans, livestock and snails, One Health surveillance system could be the most effective approach to accelerate the process of elimination or consolidate the achievement of schistosomiasis by integrating the risk surveillance and novel diagnostic tools in the intelligent multi-point trigger infectious disease monitoring and early warning system.
Keywords: Elimination; One Health; Schistosomiasis; Surveillance.
© 2025 The Author(s).
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Jing Xu reports financial support was provided by National Science Foundation of China. Jing Xu serves as a member of the Editorial Board of Science in One Health. To minimize any potential conflicts of interest, she was not involved in the editorial review or decision-making process for this manuscript. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures


Similar articles
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Tobacco packaging design for reducing tobacco use.Cochrane Database Syst Rev. 2017 Apr 27;4(4):CD011244. doi: 10.1002/14651858.CD011244.pub2. Cochrane Database Syst Rev. 2017. PMID: 28447363 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240. Health Technol Assess. 2006. PMID: 16796930
References
-
- World Health Organization, Schistosomiasis (Bilharzia) 2024. https://www.who.int/health-topics/schistosomiasis#tab=tab_1 (accessed 31 May 2024)
Publication types
LinkOut - more resources
Full Text Sources